Figure 5.
The psoriasis-like skin sections were strained by immunohistochemistry to evaluate F4/80 in five groups. (A) Control group. (B) IMQ-treated group. (C) Withanolides 500 mg/kg group. (D) Withanolides 250 mg/kg group. (E) MTX-treated group. (F) F4/80 positive cell/field (IF ×400). *** p < 0.001 vs. IMQ-treated group, ### p < 0.001 vs. control group.